>Enoxaparin is an effective and safe alternative to unfractionated heparin (UFH) in the early and invasive management of high-risk patients with non-ST-elevation acute coronary syndromes (ACS), said Robert Califf, MD, at the 53rd Annual Scientific Session of the American College of Cardiology (ACC).

Get the latest industry news, event updates, and more from Managed healthcare Executive.

Subscribe Now!

Enoxaparin clinically equivalent to UFH in the treatment of high-risk ACS

Newsletter